Review: taking Neurontin and Methamphetamine hydrochloride together


Summary

Drug interactions are reported among people who take Neurontin and Methamphetamine hydrochloride together. This review analyzes the effectiveness and drug interactions between Neurontin and Methamphetamine hydrochloride. It is created by eHealthMe based on reports of 53 people who take the same drugs from FDA and social media, and is updated regularly.

You are not alone

Join a support group for people who take Neurontin and Methamphetamine hydrochloride >>>

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>


Neurontin

Neurontin has active ingredients of gabapentin. It is often used in pain. (latest outcomes from Neurontin 56,882 users)

Methamphetamine Hydrochloride

Methamphetamine hydrochloride has active ingredients of methamphetamine. It is often used in recreational. (latest outcomes from Methamphetamine hydrochloride 814 users)

On Jul, 20, 2016

53 people who take Neurontin, Methamphetamine Hydrochloride are studied.


Number of reports submitted per year:

Neurontin and Methamphetamine hydrochloride drug interactions.

Drug effectiveness over time:

Neurontin:
  • < 1 month: 0.0% - (0 of 0 people)
  • 1 - 6 months: 0.0% - (0 of 1 people)
  • 6 - 12 months: 0.0% - (0 of 0 people)
  • 1 - 2 years: 0.0% - (0 of 0 people)
  • 2 - 5 years: 0.0% - (0 of 0 people)
  • 5 - 10 years: 0.0% - (0 of 0 people)
  • 10+ years: 0.0% - (0 of 0 people)
  • not specified: 0.0% - (0 of 0 people)
Methamphetamine Hydrochloride:
  • < 1 month: 0.0% - (0 of 0 people)
  • 1 - 6 months: 100.0% - (1 of 1 people)
  • 6 - 12 months: 0.0% - (0 of 0 people)
  • 1 - 2 years: 0.0% - (0 of 0 people)
  • 2 - 5 years: 0.0% - (0 of 1 people)
  • 5 - 10 years: 0.0% - (0 of 0 people)
  • 10+ years: 0.0% - (0 of 0 people)
  • not specified: 0.0% - (0 of 0 people)

Drug effectiveness by gender:

Neurontin:
  • female: 0.0% - (0 of 1 people)
  • male: 0.0% - (0 of 0 people)
Methamphetamine Hydrochloride:
  • female: 100.0% - (1 of 1 people)
  • male: 0.0% - (0 of 1 people)

Drug effectiveness by age:

Neurontin:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 0.0% - (0 of 0 people)
  • 30-39: 0.0% - (0 of 0 people)
  • 40-49: 0.0% - (0 of 1 people)
  • 50-59: 0.0% - (0 of 0 people)
  • 60+: 0.0% - (0 of 0 people)
Methamphetamine Hydrochloride:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 0.0% - (0 of 0 people)
  • 30-39: 0.0% - (0 of 0 people)
  • 40-49: 100.0% - (1 of 1 people)
  • 50-59: 0.0% - (0 of 0 people)
  • 60+: 0.0% - (0 of 1 people)

Most common drug interactions over time *:

1 - 6 months:
  • sweating
  • tardive dyskinesia
2 - 5 years:
  • completed suicide
  • tinnitus
  • alcoholism
  • belligerence
  • cardiac arrest
  • coma
  • drug abuser
  • marital problem
  • personality change
  • road traffic accident
not specified:
  • fatigue
  • pain
  • weight increased
  • anxiety
  • back pain
  • diarrhoea
  • hypercholesterolaemia
  • injury
  • osteoarthritis
  • hiatus hernia

Most common drug interactions by gender *:

female:
  • anxiety
  • back pain
  • diarrhoea
  • hypercholesterolaemia
  • injury
  • osteoarthritis
  • pain
  • weight increased
  • hiatus hernia
  • oesophagitis
male:
  • road traffic accident
  • fatigue
  • loss of consciousness
  • murder
  • completed suicide
  • accident
  • amnesia
  • difficulty in walking
  • drug abuser
  • impaired driving ability

Most common drug interactions by age *:

10-19:
  • completed suicide
20-29:
  • oedema peripheral
  • weight increased
30-39:
  • anxiety
  • arthralgia
  • back pain
  • bone disorder
  • cervical dysplasia
  • cervix carcinoma
  • clostridium difficile colitis
  • dermatitis contact
  • diarrhoea
  • dysarthria
40-49:
  • sweating
  • tardive dyskinesia
50-59:
  • amnesia
  • abdominal discomfort
  • abdominal distension
  • abdominal pain upper
  • acne
  • actinic keratosis
  • adnexa uteri mass
  • anaemia
  • anhedonia
  • animal bite
60+:
  • tinnitus

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you take Neurontin and Methamphetamine hydrochloride?

Can you answer these questions?

More questions for: Neurontin, Methamphetamine hydrochloride

You may be interested in these reviews

More reviews for: Neurontin, Methamphetamine hydrochloride

On eHealthMe, Neurontin (gabapentin) is often used to treat pain. Methamphetamine hydrochloride (methamphetamine) is often used to treat recreational. Find out below the conditions the drugs are used for and how effective they are.

What is the drug used for and how effecitve is it:


NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.